Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03181100
Title Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

thyroid gland carcinoma

thyroid gland anaplastic carcinoma


Atezolizumab + Cobimetinib

Atezolizumab + Bevacizumab

Atezolizumab + Nab-paclitaxel

Atezolizumab + Cobimetinib + Vemurafenib

Atezolizumab + Paclitaxel

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST